190
Participants
Start Date
July 27, 2023
Primary Completion Date
February 28, 2025
Study Completion Date
December 30, 2025
Pemvidutide
Administered by subcutaneous injection
Placebo
Administered by subcutaneous injection
Royal Prince Alfred Hospital, Camperdown
Liverpool Hospital, Liverpool
St. Vincent's Hospital Melbourne, Fitzroy
Austin Health, Heidelberg
Box Hill Hospital, Box Hill
Monash Hospital, Clayton
Princess Alexandra Hospital/ Translational Research Institute, Woolloongabba
Flinders Medical Centre, Bedford Park
Sir Charles Gairdner Hospital, Nedlands
Fiona Stanley Hospital, Murdoch
Altimmune Clinical Study Site, Marietta
Altimmune Clinical Study Site, Dalton
Altimmune Clinical Study Site, Port Orange
Altimmune Clinical Study Site, Miami Lakes
Altimmune Clinical Study Site, Hialeah Gardens
Altimmune Clinical Study Site, North Hollywood
Altimmune Clinical Study Site, West Palm Beach
Altimmune Clinical Study Site, Fort Myers
Altimmune Clinical Study Site, Bradenton
Altimmune Clinical Study Site, Sarasota
Altimmune Clinical Study Site, Clarksville
Altimmune Clinical Study Site, Germantown
Altimmune Clinical Study Site, Shreveport
Altimmune Clinical Study Site, Austin
Altimmune Clinical Study Site, Houston
Altimmune Clinical Study Site, Bellaire
Altimmune Clinical Study Site, San Antonio
Altimmune Clinical Study Site, San Antonio
Altimmune Clinical Study Site, Edinburg
Altimmune Clinical Study Site, Edinburg
Altimmune Clinical Study Site, Bastrop
Altimmune Clinical Study Site, Georgetown
Altimmune Clinical Study Site, Englewood
Altimmune Clinical Study Site, West Jordan
Altimmune Clinical Study Site, Chandler
Altimmune Clinical Study Site, Peoria
Altimmune Clinical Study Site, Tucson
Altimmune Clinial Study Site, Tucson
Altimmune Clinical Study Site, Panorama City
Altimmune Clinical Study Site, San Juan
Lead Sponsor
Altimmune, Inc.
INDUSTRY